Category VIEW ALL
Cysteine Depletion as a Treatment for Obesity and Associated Metabolic Disorders
Technology No. LIT01-56
Novel Probiotic Compositions for Improving Metabolism and Immunity
Technology No. BLA02-12
Netrin-1 and UNC5B as Novel Targets in Metabolic Liver Diseases: NAFLD & NASH
Technology No. MOO02-06
Chimeric FGF21: Treatment of NAFLD, NASH and Hepatic Steatosis
Technology No. MOH01-03
Transgenic Mouse Model Expressing C217G Uromodulin
Technology No. WU01-01
